A
Live / Applied — Third extension granted (statement of use) (as of 13 Aug 2025)
What this means for you
Not registered yet, but its 09 May 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97928168
- Mark type
- Design + words
- Filed
- 09 May 2023
- Published for opposition
- 30 Jan 2024
- Attorney of record
- Kevin S. Costanza
Goods and services
- Class 005 — Pharmaceuticals: Prescription pharmaceutical preparations, prescription pharmaceutical compounds in the nature of small molecule chemical compounds, and prescription pharmaceutical compositions for use in the prevention and treatment of neurodegenerative, neurologic, neuropsychiatric and inflammatory disorders such as Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, neuropathy and neuropathic pain, Stroke, Depression, Insomnia, Schizophrenia, Hearing Loss and Rheumatoid Arthritis
- Class 042 — Scientific and technological services: Pharmaceutical research and development; pharmaceutical drug development services
Owner
- Athira Pharma, Inc., Bothell, WA, US
- Athira Pharma, Inc., Bothell, WA, US
Prosecution history
- 14 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Aug 2025 — SOU EXTENSION 3 GRANTED
- 13 Aug 2025 — SOU EXTENSION 3 FILED
- 13 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 05 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Mar 2025 — SOU EXTENSION 2 GRANTED
- 04 Mar 2025 — SOU EXTENSION 2 FILED
- 04 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 13 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Apr 2024 — SOU EXTENSION 1 GRANTED
- 12 Apr 2024 — SOU EXTENSION 1 FILED
- 12 Apr 2024 — SOU TEAS EXTENSION RECEIVED
- 26 Mar 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Jan 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Jan 2024 — PUBLISHED FOR OPPOSITION